Uses and limitations of monoclonal antibodies (MoAbs) in the treatment of malignant disease: a review (Q70746280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

review article

1 reference

title

Uses and limitations of monoclonal antibodies (MoAbs) in the treatment of malignant disease: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

Kemshead JT

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Hopkins K

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

language of work or name

English

0 references

publication date

1 April 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Royal Society of Medicine

13 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

219-224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia

13 October 2019

cites work

1 reference

12 December 2020

Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice

1 reference

12 December 2020

Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.

1 reference

12 December 2020

Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases

1 reference

12 December 2020

Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: tumoricidal effects and distribution studies

1 reference

12 December 2020

131-I coupled to monoclonal antibodies as therapeutic agents for neuroectodermally derived tumors: fact or fiction?

1 reference

12 December 2020

Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.

1 reference

12 December 2020

Comparison of monoclonal antibody delivery to intracranial glioma xenografts by intravenous and intracarotid administration.

1 reference

12 December 2020

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies

1 reference

12 December 2020

Transport of molecules across tumor vasculature

1 reference

12 December 2020

Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.

1 reference

12 December 2020

Immunotoxins: a clinical review of their use in the treatment of malignancies

1 reference

12 December 2020

Monoclonal antibodies in the diagnosis and treatment of human diseases

1 reference

12 December 2020

Iodine-125-labeled anti-epidermal growth factor receptor-425 in the treatment of glioblastoma multiforme. A pilot study.

1 reference

12 December 2020

High-dose radioimmunotherapy of B cell lymphomas

1 reference

12 December 2020

Intraperitoneally administered 90Y-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions

1 reference

12 December 2020

Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis

1 reference

12 December 2020

Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).

1 reference

12 December 2020

A pilot study of monoclonal antibody targeted radiotherapy in the treatment of central nervous system leukaemia in children

1 reference

12 December 2020

Iodine125 labeled anti-epidermal growth factor receptor-425 in the treatment of malignant astrocytomas. A pilot study

1 reference

12 December 2020

A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG).

1 reference

12 December 2020

Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8505732%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

PubMed publication ID

8505732

1 reference